UBS reiterates Buy on Protagonist Therapeutics stock citing Mimrylo launch progress Investing.com · News 8m ago
UBS raises Iovanace Biotherapeutics price target to $8 on revenue outlook Investing.com · News 8m ago
UBS raises IDEXX Laboratories stock price target on strong international growth Investing.com · News 14m ago
Piper Sandler raises Palantir stock price target to $235 on revenue growth Investing.com · News 14m ago
Wells Fargo cuts Cipher Mining stock price target on campus delivery timeline Investing.com · News 14m ago
Wells Fargo raises Checkpoint Software stock price target on 2027 outlook Investing.com · News 14m ago